Formpipe - Investments in Growth
2022-05-02 09:45:00
Redeye retains its positive view on Formpipe despite forecasting zero margins in 2022. We believe growth investments will hurt earnings in 2022/23 but simultaneously pave the way for strong SaaS growth with high scalability for many years. We expect Formpipe to reach its EBIT margin target (>20%) in 2026.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/